Researchers in Cancer and Haematology

Hans-Olov Adami, Cancer epidemiology

Olof Akre, Urology

Sonia Andersson, Gynaecological cancer

Elias Arnér, Selenoproteins

Marie Arsenian Henriksson, MYC genes

Peter Aspelin, Diagnostic radiology

Jiri Bártek, Cancer Biology

Dzevad Belkic, Mathematical radiation physics

Jonas Bergh, Breast cancer

Christer Betsholtz, Vascular biology

Mikael Björnstedt, Selenoproteins

Klas Blomgren, childhood cancer and the developing brain

Lennart Blomqvist, Medical Radiology specialising in Oncology

Anders Brahme, Medical radiation physics

Yvonne Brandberg, Care sciences with focus on oncology

Richard Rosenquist Brandell, Clinical Genetics

Yihai Cao, Mechanisms behind pathological angiogenesis

Tina Dalianis, Tumour virology

Lars Egevad, Urological cancer

Stefan Einhorn, Molecular oncology

Karin Ekström Smedby, Haematology-Oncology and Clinical Epidemiology

Lennart Eriksson, Prevention of liver cancer in patients with chronic liver diseases

Ingemar Ernberg, Tumour biology

Bengt Fadeel, Cell death and cell clearance

Marianne Farnebo, WRAP53

Óscar Fernández-Capetillo, Cancer Therapy

Teresa Frisan, Characterization of the carcinogenic properties of bacterial genotoxins

Jan Frisell, Breast cancer surgery

Susanne Gabrielsson, Immunology and exosomes

Leonard Girnita, Molecular function and targeting of beta-arrestins in cancer

Roland Grafström, Experimental cancer research

Per Hall, Radiation epidemiology and breast cancer

Johan Hansson, Malignant melanoma

Moustapha Hassan, Experimental haematology

Thomas Helleday, Synthetic lethality

Eva Hellström-Lindberg, Myelodysplastic syndrome

Ola Hermanson, Neuroscience and Childhood Cancer

Torbjörn Holm, Colorectal surgery

Arne Holmgren, Thioredoxin and glutaredoxin systems

Lars Holmgren, Tumour biology

Rolf Hultcrantz, Metabolic and inflammatory diseases of the liver

Keith Humphreys, biostatistics in breast cancer epidemiology

Johan Högberg, Toxicology

Magnus Ingelman-Sundberg, Pharmacogenetics

Hans Jacobsson, Nucleo medicine

Randall S. Johnson, Molecular biology and oxygen physiology

Bertrand Joseph, Apoptosis

Rolf Kiessling, Immune and gene therapy

Eva Klein, Tumour biology

Per Kogner, Neuroblastoma

Svetlana Lagercrantz, Medical genetics

Jesper Lagergren, Cancer of the oesophagus and stomach

Pernilla Lagergren, Surgical care sciences

Sonia Lain, Molecular tumour biology

Sir David Lane, Tumour Suppressor Biology, p53

Catharina Larsson, Medical genetics

Jörgen Larsson, Surgery

Lars-Gunnar Larsson, MYC genes

Ola Larsson, Molecular biology

Olle Larsson, IGF-1R and its role in malignant cell growth

Sören Lehmann, Acute myeloid leukemia

Janne Lehtiö, Cancer proteomics to improve therapy

Rolf Lewensohn, Molecular radiation oncology

Stig Linder, Molecular Cancer Pharmacology

Per Ljungman, Viral infections in allogeneic stem cell transplant patients

Weng-Onn Lui, Medical genetics

Karl-Johan Malmberg, Optimizing NK cell therapy for hematological malignancies

Mats Marshall Heyman, Childhood cancer epidemiology

Anna Martling, Colorectal surgery

Maria Masucci, Molecular mechanisms of viral oncogenesis

Håkan Mellstedt, Cancer vaccine research

Stephan Mielke, Haematology and Cell Therapy

Ralf Morgenstern, Biochemical toxicology

Hareth Nahi, Multiple myeloma

Magnus Nilsson, Surgery

Monica Nistér, Brain tumour models

Magnus Nordenskjöld, Clinical genetics

Rolf Ohlsson, Genomic integrity

Sten Orrenius, Molecular mechanisms of cell death and implication in disease

Jan Palmblad, Inflammation and haematology research

Theocharis Panaretakis, Exosome-based biomarkers and novel cancer therapies

Manuel Patarroyo, Adhesion molecules in inflammation and cancer

Teresa Pereira, Regulation of HIF-1 alpha function

Johan Permert, Pancreatic cancer and diabetes

Agneta Rannug, Molecular work environment toxicology

Ulrik Ringborg, Oncology

Olle Ringdén, Allogeneic hematopoietic stem cell transplantation

Charlotte Rolny, Tumour immunology

Kerstin Sandelin, Breast surgery

Birgitta Sander, Molecular pathogenesis of malignant lymphoma

Susanne Schlisio, Cancer biology

Galina Selivanova, p53

Gunnar Steineck, Clinical cancer epidemiology

Sharon Stone-Elander, Cognitive neurophysiology - medical radiochemistry

Peter Strang, Palliative oncology

Anders Sundin, Diagnostic radiology

Laszlo Szekely, Haematological malignant diseases

Margaret Sällberg Chen, Clinical oral immunology and cancer

Jussi Taipale, Medical system biology

Rune Toftgård, Hedgehog signalling in embryonic development and carcinogenesis

Carl-Magnus Wahlgren, Trauma surgery and the blood's ability to coagulate

Margareta Wilhelm, Tumor microenvironment and cancer models

Klas Wiman, p53, Wig-1 and PRIMA-1/APR-246

Jan Zedenius, Surgery specialising in Endocrine Surgery

Anders Zetterberg, Tumour cytology

Boris Zhivotovsky, Molecular mechanisms of cell death and implication in disease

Arne Östman, Tumour stroma and protein tyrosine phosphatases